1996 Jun 01
[3] It is theorized that Sermorelin might initiate various intracellular signaling events upon engaging with these receptors
Moreover, NAC can also be one choice as a synergistic treatment for OCRDs and OCSDs, but further studies are needed to confirm this
BPC-157/TB-500/KPV/GHK-Cu 10+10+10+50mg (KLOW blend 80mg) $225.00 Volume discounts Auto-applied at checkout Free shipping on orders of $200+ Compound Identity COMPOUND NAME BPC+TB500+GHK-Cu+KPV SYNONYMS KLOW blend CAS NUMBER 137525-51-0 (BPC-157), 77591-33-4 (TB500), 300801-03-0 (GHK-Cu), 2828433-34-5 (KPV) MOLECULAR FORMULA C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu), C 18 H 34 N 4 O 6 (KPV) MOLECULAR WEIGHT ~7189 g/mol STRUCTURE Multi-peptide blend PEPTIDE SEQUENCE Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (BPC-157), Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (TB500), Gly-His-Lys (GHK-Cu), Lys-Pro-Val (KPV) CHEMICAL STRUCTURE Molecular Formula : C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu), C 18 H 34 N 4 O 6 (KPV) Source: PubChem Mechanism of Action The KLOW blend acts on multiple cellular pathways that regulate inflammation, tissue repair, angiogenesis, and oxidative balance
Improves Physical Performance: Increases Stamina and Overall Physical Capability
Subcellular measurements demonstrated distinct acyl-CoA profiles in mitochondria versus cytosol, including a clear cytosolic acetyl-CoA pool in the DKO cells (Figure 2D)
